{"id":"https://openalex.org/A5028667662","orcid":"https://orcid.org/0009-0000-7364-6820","observed_orcids":["https://orcid.org/0009-0000-7364-6820"],"display_name":"Anna Fornwall","raw_author_names":["A Fornwall","A. Fornwall","Anna Fornwall"],"full_name":"Anna Fornwall","works_count":5,"cited_by_count":67,"summary_stats":{"2yr_mean_citedness":0.0,"h_index":2,"i10_index":2},"ids":{"openalex":"https://openalex.org/A5028667662","orcid":"https://orcid.org/0009-0000-7364-6820","observed_orcids":["https://orcid.org/0009-0000-7364-6820"]},"affiliations":[{"institution":{"id":"https://openalex.org/I4210148008","ror":"https://ror.org/05nqb8479","display_name":"Quantify Research (Sweden)","country_code":"SE","type":"company","lineage":["https://openalex.org/I4210148008"]},"years":[2023,2022,2021]}],"last_known_institutions":[{"id":"https://openalex.org/I4210148008","ror":"https://ror.org/05nqb8479","display_name":"Quantify Research (Sweden)","country_code":"SE","type":"company","lineage":["https://openalex.org/I4210148008"]}],"topics":[{"id":"https://openalex.org/T10198","display_name":"Heart Failure Treatment and Management","count":3,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11305","display_name":"Amyloidosis: Diagnosis, Treatment, Outcomes","count":3,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","count":2,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10202","display_name":"Lung Cancer Diagnosis and Treatment","count":1,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","count":1,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"topic_share":[{"id":"https://openalex.org/T11305","display_name":"Amyloidosis: Diagnosis, Treatment, Outcomes","value":3.58e-05,"subfield":{"id":"https://openalex.org/subfields/2724","display_name":"Internal Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12708","display_name":"Economic and Financial Impacts of Cancer","value":1.56e-05,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11335","display_name":"Prion Diseases and Protein Misfolding","value":1.42e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12246","display_name":"Chronic Disease Management Strategies","value":1.05e-05,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10198","display_name":"Heart Failure Treatment and Management","value":9.4e-06,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"x_concepts":[{"id":"121157162","wikidata":"https://www.wikidata.org/wiki/Q419999","display_name":"Transthyretin","score":0.9495224356651306},{"id":"71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","score":0.935917854309082},{"id":"126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","score":0.5442498326301575},{"id":"164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","score":0.4167027473449707},{"id":"142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","score":0.21587151288986206}],"counts_by_year":[{"year":2021,"works_count":1,"oa_works_count":1,"cited_by_count":0},{"year":2022,"works_count":3,"oa_works_count":3,"cited_by_count":2},{"year":2023,"works_count":1,"oa_works_count":1,"cited_by_count":16},{"year":2024,"works_count":0,"oa_works_count":0,"cited_by_count":17},{"year":2025,"works_count":0,"oa_works_count":0,"cited_by_count":15},{"year":2026,"works_count":0,"oa_works_count":0,"cited_by_count":17}],"display_name_alternatives":["A Fornwall","A. Fornwall","Anna Fornwall"],"block_key":"a fornwall","works_api_url":"https://api.openalex.org/works?filter=author.id:A5028667662","awards_count":0,"updated_date":"2026-11-04T11:47:51","created_date":"2021-11-08T00:00:00"}